View Our Latest Perspectives
Innovative ideas and insights
Read More
Browse our recent transactions, perspectives and news
CLEVELAND, Oct. 2, 2017 /PRNewswire/ -- KeyBanc Capital Markets Inc., the corporate and investment banking unit ...
Banker Commentary: Elizabeth Kim argues that, no matter what the Trump administration proposes or does, the healthcare ...
Banker Commentary: Thomas Culhane brings us up to date on the status of the Disproportionate Share Hospital ...
Banker Commentary: Ben Herbert describes several unique physician group affiliation transactions that preserved local control and physician ...
Banker Commentary: John Kerins highlights Novartis’ Kymriah, which is the first FDA-approved gene therapy drug, and points ...
Tax-exemption is a double-edged sword for not-for-profit (NFP) health systems. It offers sizable financial benefits, but ...
